• Explore /
  • Poster
  • / Primary ipilimumab/nivolumab followed by adjuvant nivolumab in patients with locally advanced or oligometastatic melanoma: Update on outcome.

Primary ipilimumab/nivolumab followed by adjuvant nivolumab in patients with locally advanced or oligometastatic melanoma: Update on outcome.

Abstract Poster

Authors

null

Emilia Cocorocchio

Istituto Europeo di Oncologia, IRCCS, Milano, Italy

Emilia Cocorocchio , Sara Gandini , Luigi Nezi , Teresa Manzo , Luca Mazzarella , Massimo Barberis , Luisa Lanfrancone , Laura Pala , Fabio Conforti , Elisabetta Pennacchioli , Gianmarco Orsolini , Maria Teresa Fierro , Pietro Quaglino , Rebecca Senetta , Virginia Caliendo , Concetta Riviello , Sara Stucchi , Angeli Dominique Macandog , Gianmaria Frige , Pier Francesco Ferrucci

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Melanoma/Skin Cancers

Track

Melanoma/Skin Cancers

Sub Track

Local-Regional Disease

Clinical Trial Registration Number

2018-002172-40

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 9574)

DOI

10.1200/JCO.2022.40.16_suppl.9574

Abstract #

9574

Poster Bd #

167

Abstract Disclosures

Similar Posters

First Author: Milton Jose De Barros E Silva

First Author: Toshiharu Hirose

First Author: Yara L. Verschoor

First Author: Ahmed Omar Kaseb